Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC - EurekAlert!
EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC - EurekAlert!
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC - EurekAlert!
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC - EurekAlert!
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC - EurekAlert!
Neopred: A dual-phase CT AI tool for preoperative prediction of pathological response in NSCLC - EurekAlert!
Organ preservation strategies: Extended sleeve lobectomy after neoadjuvant immunochemotherapy offers optimal option for centrally located NSCLC - EurekAlert!
